In humans, multiple lines of evidence support both pro- and anti-tumorigenic roles for NRF2 including during skin cancer development and progression [69], a phenomenon that can also be observed in gain- and loss-of-function animal models. This evidence concerns the gene NFE2L2 and skin cancer.